Chimeric Therapeutics LimitedASX: CHM

Successful completion of Institutional Entitlement Offer

· Issued by Chimeric Therapeutics Limited

Filed with ASX · · 2 pages · English

Chimeric Therapeutics Limited (ASX:CHM) (ChimericorCompany) refers to its announcement of 21 February 2022 in relation to an equity raising being undertaken by the Company by way of an accelerated 1 for 3.15 non-renounceable entitlement offer to raise approximately $18.1 million (before costs of the offer) (Entitlement Offer). The Entitlement Offer includes an institutional component (Institutiona

Chimeric Therapeutics Limited on 6ix

In the deck

Earlier from Chimeric Therapeutics

Later from Chimeric Therapeutics

All Chimeric Therapeutics news releases